glucuronic acid has been researched along with indinavir sulfate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
House, L; Liu, Y; RamÃrez, J; Ratain, MJ | 1 |
Del Sole, MJ; E Lanusse, C; Imperiale, JC; Nejamkin, P; Sosnik, A | 1 |
2 other study(ies) available for glucuronic acid and indinavir sulfate
Article | Year |
---|---|
Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
Topics: Adolescent; Adult; Aged; Area Under Curve; Bilirubin; Binding, Competitive; Biocatalysis; Cell Line; Child; Drug Interactions; Erlotinib Hydrochloride; Female; Gefitinib; Glucuronic Acid; Glucuronosyltransferase; Humans; Hymecromone; Imipramine; Indinavir; Isoenzymes; Kinetics; Male; Microsomes, Liver; Middle Aged; Models, Biological; Protein Kinase Inhibitors; Quinazolines; Recombinant Proteins; Young Adult | 2010 |
Novel protease inhibitor-loaded Nanoparticle-in-Microparticle Delivery System leads to a dramatic improvement of the oral pharmacokinetics in dogs.
Topics: Adhesiveness; Administration, Oral; Alginates; Animals; Cattle; Chitosan; Dogs; Dose-Response Relationship, Drug; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Indinavir; Nanoparticles; Protease Inhibitors; Spectroscopy, Fourier Transform Infrared; Time Factors; X-Ray Diffraction | 2015 |